Current Value of Holding

$493M

Shares

3.98M

% of Portfolio

0.32%

Average Buy Price

$75

Avg closing price
Price range

51 Ken Griffin Gilead Sciences Trades

Ken Griffin acquired 600k Gilead Sciences shares worth $74.3M. That's 0.05% of their equity portfolio (456th largest holding). The first Gilead Sciences trade was made in Q2 2013. Since then Ken Griffin bought shares 62 more times and sold shares on 64 occasions. The stake costed the investor $45.3M, netting the investor a gain of 64% so far.

Avg closing price
Price range
Increased shares by 2.4% (+94.7k shares) Q1 2026
Avg closing price $140.42
Price range $118.30 - $155.80
Sold 25.4% shares (-1.32M shares) Q4 2025
Avg closing price $121.62
Price range $110.56 - $128.07
Sold 4.8% shares (-263k shares) Q3 2025
Avg closing price $113.63
Price range $108.22 - $120.47
Increased shares by 1.8% (+96.6k shares) Q2 2025
Avg closing price $106.47
Price range $96.91 - $113.00
Increased shares by 14.4% (+678k shares) Q1 2025
Avg closing price $102.80
Price range $89.14 - $117.41
Sold 6.4% shares (-322k shares) Q4 2024
Avg closing price $90.22
Price range $83.94 - $97.90
Increased shares by 1702.5% (+4.74M shares) Q3 2024
Avg closing price $76.20
Price range $66.59 - $83.99
Sold 94.8% shares (-5.04M shares) Q2 2024
Avg closing price $66.73
Price range $63.15 - $72.88
Increased shares by 1226.4% (+4.92M shares) Q1 2024
Avg closing price $76.90
Price range $71.58 - $87.29
Increased shares by 2.4% (+9.29k shares) Q4 2023
Avg closing price $77.82
Price range $73.27 - $83.09
Increased shares by 31.1% (+93.1k shares) Q3 2023
Avg closing price $76.92
Price range $73.94 - $80.67
Sold 86.7% shares (-1.95M shares) Q2 2023
Avg closing price $79.75
Price range $76.01 - $86.70
Increased shares by 36.1% (+597k shares) Q1 2023
Avg closing price $82.82
Price range $77.31 - $88.08
Increased shares by 384.7% (+1.31M shares) Q4 2022
Avg closing price $79.19
Price range $62.32 - $89.47
Sold 89.1% shares (-2.79M shares) Q3 2022
Avg closing price $63.06
Price range $59.54 - $68.01
Increased shares by 27.7% (+677k shares) Q2 2022
Avg closing price $61.91
Price range $57.72 - $65.01
Increased shares by 268.7% (+1.79M shares) Q1 2022
Avg closing price $63.92
Price range $57.92 - $72.58
Increased shares by 67.6% (+268k shares) Q4 2021
Avg closing price $68.88
Price range $64.88 - $73.64
Sold 65.7% shares (-759k shares) Q3 2021
Avg closing price $70.25
Price range $67.69 - $73.03
Sold 81.1% shares (-4.97M shares) Q2 2021
Avg closing price $66.77
Price range $63.47 - $69.35

News about Gilead Sciences, Inc. and Ken Griffin

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!